Contribution of dopamine in the anti-hypertensive effect of central tachykinin NK-3 receptor antagonists in spontaneously hypertensive rat

被引：0
|
作者：
Pereira, H. De Brito [1 ]
Couture, R. [1 ]
机构：
[1] Univ Montreal, Montreal, PQ, Canada
来源：
JOURNAL OF HYPERTENSION | 2007年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S243 / S243
页数：1
相关论文
共 50 条
  • [41] D1 dopamine receptor regulation of NHE3 during development in the spontaneously hypertensive rat
    Li, XX
    Albrecht, FE
    Robillard, JE
    Eisner, GM
    Jose, PA
    PEDIATRIC RESEARCH, 2000, 47 (04) : 448A - 448A
  • [42] κ-Opioid receptors behind the blood-brain barrier are involved in the anti-hypertensive effects of systemically administered κ-agonists in the conscious spontaneously hypertensive rat
    Shen, S
    Ingenito, AJ
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (11) : 1251 - 1256
  • [43] THE EFFECTS OF THROMBOXANE RECEPTOR ANTAGONISTS ON ESTROGEN-INDUCED UTEROTROPHIC RESPONSES IN THE SPONTANEOUSLY HYPERTENSIVE RAT
    KERR, MB
    MARSHALL, K
    SENIOR, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (02) : 1363 - 1366
  • [44] Reduced inflammation in genetically hypertensive rat airways is associated with reduced tachykinin NK1 receptor numbers
    Campbell, VA
    Beddy, P
    Foley, A
    Bakhle, YS
    Bell, C
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 401 (01) : 109 - 114
  • [45] Implication of nigral tachykinin NK3 receptors in the maintenance of hypertension in spontaneously hypertensive rats:: a pharmacologic and autoradiographic study
    Lessard, A
    Campos, MM
    Neugebauer, W
    Couture, R
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (04) : 554 - 563
  • [46] THE EFFECT OF PROPRANOLOL ON CENTRAL NOREPINEPHRINE AND SEROTONIN RELEASE IN THE SPONTANEOUSLY HYPERTENSIVE RAT (SHR)
    HALL, JS
    BIEDIGER, AM
    KEETON, TK
    FEDERATION PROCEEDINGS, 1983, 42 (04) : 766 - 766
  • [47] Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist
    Sarau, HM
    Griswold, DE
    Bush, B
    Potts, W
    Sandhu, P
    Lundberg, D
    Foley, JJ
    Schmidt, DB
    Webb, EF
    Martin, LD
    Legos, JJ
    Whitmore, RG
    Barone, FC
    Medhurst, AD
    Luttmann, MA
    Giardina, GAM
    Hay, DWP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 295 (01): : 373 - 381
  • [48] Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat
    Cellier, E
    Barbot, L
    Iyengar, S
    Couture, R
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (03) : 717 - 728
  • [49] Dopamine-β-monooxygenase inhibitors obtained by structure based methods exhibited anti-hypertensive effect in L-NAME induced hypertensive rats
    Dey, Sanjay Kumar
    Prabhakar, Pankaj
    Saini, Manisha
    Joseph, Toyanji
    Thelma, B. K.
    Maulik, Subir K.
    Kundu, Suman
    FASEB JOURNAL, 2018, 32 (01):
  • [50] Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat
    Cellier, E
    Barbot, L
    Regoli, D
    Couture, R
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (04) : 643 - 654
12345